Related Experiment Video
Updated: Apr 9, 2026

Mammosphere Assay Reveals Api5-Induced Stemness in Non-Tumorigenic Breast Epithelial Cell Lines
Published on: February 24, 2026
Critical Role for the DNA Sensor AIM2 in Stem Cell Proliferation and Cancer
Si Ming Man1, Qifan Zhu2, Liqin Zhu3
1Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Abstract:
Colorectal cancer is a leading cause of cancer-related deaths. Mutations in the innate immune sensor AIM2 are frequently identified in patients with colorectal cancer, but how AIM2 modulates colonic tumorigenesis is unknown. Here, we found that Aim2-deficient mice were hypersusceptible to colonic tumor development. Production of inflammasome-associated cytokines and other inflammatory mediators was largely intact in Aim2-deficient mice; however, intestinal stem cells were prone to uncontrolled proliferation. Aberrant Wnt signaling expanded a population of tumor-initiating stem cells in the absence of AIM2. Susceptibility of Aim2-deficient mice to colorectal tumorigenesis was enhanced by a dysbiotic gut microbiota, which was reduced by reciprocal exchange of gut microbiota with healthy wild-type mice. These findings uncover a synergy between a specific host genetic factor and gut microbiota in determining the susceptibility to colorectal cancer. Therapeutic modulation of AIM2 expression and microbiota has the potential to prevent colorectal cancer.
Insights
The innate immune sensor AIM2 protects against colorectal cancer by controlling intestinal stem cell proliferation. Loss of AIM2, combined with gut microbiota changes, increases colon tumor development.
Area of Science:
- Oncology
- Immunology
- Microbiology
Background:
- Colorectal cancer (CRC) is a major cause of cancer mortality.
- Mutations in the Absent in Melanoma 2 (AIM2) innate immune sensor are common in CRC patients.
- The role of AIM2 in colon tumorigenesis remains unclear.
Purpose of the Study:
- To investigate the function of AIM2 in colonic tumor development.
- To explore the interplay between AIM2, intestinal stem cells, and gut microbiota in CRC susceptibility.
Main Methods:
- Utilized Aim2-deficient mouse models for colonic tumor development studies.
- Assessed inflammasome-associated cytokine production and intestinal stem cell proliferation.
- Investigated the impact of gut microbiota dysbiosis and fecal microbiota transplantation.
Main Results:
- Aim2-deficient mice exhibited increased susceptibility to colonic tumor formation.
- AIM2 deficiency led to uncontrolled intestinal stem cell proliferation and aberrant Wnt signaling.
- Gut microbiota dysbiosis exacerbated CRC susceptibility in Aim2-deficient mice, which was ameliorated by microbiota exchange.
Conclusions:
- AIM2 acts as a crucial host genetic factor suppressing colonic tumorigenesis.
- A synergistic interaction exists between AIM2 and gut microbiota in CRC development.
- Targeting AIM2 and modulating the gut microbiota show potential for CRC prevention.
More Related Videos
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation

